MEDIFAST INC
For the period ended Sep 30, 2026. Filed Oct 26, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. – Other Information
Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements
During the second quarter of 2026, Chairman of the Board Daniel R. Chard, adopted a trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c). The arrangement was entered into on May 8, 2026, and provides for the sale of up to 19,089 shares of the Company’s common stock, par value $0.001 per share, beginning September 28, 2026 and concluding September 29, 2026, subject to the terms of the arrangement. Pursuant to the terms of the trading arrangement, Mr. Chard completed the sale of all 19,089 shares of common stock on September 28, 2026, and September 29, 2026.
No other director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, during the three months ended September 30, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.